Until recently, robotic surgery has been associated only with the da Vinci robotic system. A novel Senhance® robotic system (TransEnterix Surgical Inc., Morrisville, NC, USA) was introduced almost 5 years ago. Published reports on experience using this robotic platform are very limited. We present a prospective analysis of the first 100 robotic surgeries in abdominal surgery, gynecology, and urology in Klaipeda University Hospital, Klaipeda, Lithuania. Out of 100 operated patients during the mentioned period, 49 were female and 51 men, age range 27–79 years, on an average 55 years. 39 underwent robotic abdominal surgical procedures, 31—urological, and 30 gynecological surgeries. Duration of surgery varied from 30 min to 6 h and 5 min, on an average 2 h 25 min. Almost half 49 (49%) were operated on for malignant diseases: prostate cancer—27, renal cell carcinoma—1, endometrial cancer—7, ovarian cancer—1, colorectal cancer—13 (7 colon and 6 rectum). In-hospital stay was on an average 4 days, range 1–15 days. There were 3 (3%) conversions: two to laparoscopy (both undergoing robotic radical prostatectomy) and one to open (undergoing total hysterectomy). 6 (6%) complications occurred during 30 postoperative days, 2 demanding surgery. According to the Clavien–Dido classification, they were grade II in 3, grade III a in 1 and grade III b in 2 cases. There was no mortality in this patient population. Our experience with different types of robotic surgeries allows us to state that the Senhance® robotic system is feasible and safe in general surgery, gynecology, and urology, and wider implementation of this system worldwide is simply a question of time.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
RUR, Copek K (1921). Dover Publication Inc. Mineola
Cadiere GB, Himpens J, Germay O, Izizaw R, Degueldre M, Vandromme J, Capelluto E, Bruyns J (2001) Feasibility of robotic laparoscopic surgery: 146 cases. World J Surg 25:1467–1477
Marescaux J, Leroy J, Gagner M, Rubino F, Mutter D, Vix M, Butner SE, Smith MK (2001) Transatlantic robot-assisted telesurgery. Nature 413(6854):379–380
Gidaro S, Buscarini M, Ruiz E et al (2012) Telelap Alf-X: a novel telesurgical system for the 21st century. Surg Technol Int 22:20–25
Stark M, Pomati S, D’Ambrosio A et al (2015) A new telesurgical platform—preliminary clinical results. Minim Invasive Ther Allied Technol 24:31–36
Spinelli A, David G, Gidaro S, Carvello M, Sacchi M, Montorsi M, Montroni I (2017) First experience in colorectal surgery with a new robotic platform with haptic feedback. Colorectal Dis. https://doi.org/10.1111/codi.13882
deBeche-Adams T, Eubanks WS, de la Fuente SG (2018) Early experience with the Senhance®-laparoscopic/robotic platform in the US. J Robot Surg. https://doi.org/10.1007/s11701-018-0893-3[Epub ahead of print]
Lowrance WT, Eastham JA, Savage C, Moschino AC, Laudone VP, Dechet CB et al (2012) Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States. J Urol 187:2087–2092
McGuinnes LA, Rai BP (2018) Robotics in urology. Ann R Coll Surg Engl 100(6):45–54
Ghezzi TL, Corleta OC (2016) 30 years of robotic surgery. World J Surg 40(10):2550–2557
Ramsay C, Pickard R, Robertson C, Close A, Vale L et al (2012) Systematic review and economic modeling of the relative clinical benefit and cost—effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health Technol Assess 16(41):1–313
Close A, Robertson C, Rushton S, Shirley M, Vale L et al (2013) Comparative cost-effectiveness of robot-assisted and standard laparoscopic prostatectomy as alternatives to open radical prostatectomy for treatment of men with localised prostate cancer: a Health Technology Assessment from the perspective of the UK National Health Service. Eur Urol 64(3):631–639
Rao PP (2018) Robotic surgery: new robots and finally some real competition. World J Urol 36(4):537–541
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
Rossitto C, Gueli Alletti S, Fanfani F, Fagotti A, Costantini B, Gallotta V, Selvaggi L, Monterossi G, Restaino S, Gidaro S, Scambia G (2016) Learning a new robotic surgical device: telelap Alf X in gynaecological surgery. Int J Med Robot 12(3):490–495
Hutchins AR, Manson RJ, Lerebours R, Farjat AE, Cox ML, Mann BP, Zani S Jr (2019) Objective assessment of the early stages of the learning curve for the senhance surgical robotic system. J Surg Educ. 76(1):201–214. https://doi.org/10.1016/j.jsurg.2018.06.026(Epub 2018 Aug 8 PMID: 30098933)
Gueli Alletti S, Rossitto C, Fanfani F, Fagotti A, Costantini B, Gidaro S, Monterossi G, Selvaggi L, Scambia G (2015) Telelap Alf-X-assisted laparoscopy for ovarian cyst enucleation: report of the first 10 cases. J Minim Invasive Gynecol 22(6):1079–1083
Fanfani F, Restaino S, Gueli Alletti S, Fagotti A, Monterossi G, Rossitto C, Costantini B, Scambia G (2015) TELELAP ALF-X robotic-assisted laparoscopic hysterectomy: feasibility and perioperative outcomes. J Minim Invasive Gynecol 22(6):1011–1017
Fanfani F, Monterossi G, Fagotti A, Rossitto C, Gueli Alletti S, Costantini B, Gallotta V, Selvaggi L, Restaino S, Scambia G (2016) The new robotic TELELAP ALF-X in gynecological surgery: single-center experience. Surg Endosc 30(1):215–221
Fanfani F, Restaino S, Rossitto C, Gueli Alletti S, Costantini B, Monterossi G, Cappuccio S, Perrone E, Scambia G (2016) Total laparoscopic (S-LPS) versus TELELAP ALF-X robotic-assisted hysterectomy: a case-control study. J Minim Invasive Gynecol 23(6):933–938
Gueli Alletti S, Rossitto C, Cianci S, Restaino S, Costantini B, Fanfani F, Fagotti A, Cosentino F, Scambia G (2016) Telelap ALF-X vs standard laparoscopy for the treatment of early-stage endometrial cancer: a single-institution retrospective cohort study. J Minim Invasive Gynecol 23(3):378–383
Gueli Alletti S, Rossitto C, Cianci S, Perrone E, Pizzacalla S, Monterossi G, Vizzielli G, Gidaro S, Scambia G (2017) The SenhanceTM surgical robotic system (‘Senhance’) for total hysterectomy in obese patients: a pilot study. J Robot Surg. https://doi.org/10.1007/s11701-017-0718-9
Stephan D, Sälzer H, Willeke F (2018) First experiences with the new senhance® telerobotic system in visceral surgery. Visc Med 34(1):31–36
Samalavicius NE, Smolskas E, Deduchovas O, Janusonis V, Dulskas A (2019) Robotic abdominoperineal resection for pT2N0M0 low rectal cancer using the Senhance TransEnterix robotic platform—a video vignette. Colorectal Dis. https://doi.org/10.1111/codi.14638[Epub ahead of print] No abstract available PMID:30977276
Samalavicius NE, Smolskas E, Deduchovas O, Janusonis V, Dulskas A (2019) Robotic right colectomy using new Senhance® robotic platform: a three-trocar technique—video vignette. Colorectal Dis 1:1. https://doi.org/10.1111/codi.14712[Epub ahead of print] PMID:31100195
Melling N, Barr J, Schmitz R, Polonski A, Miro J, Ghadban T, Wodack K, Izbicki J, Zani S, Perez D (2018) Robotic cholecystectomy: first experience with the new Senhance robotic system. J Robot Surg. https://doi.org/10.1007/s11701-018-0877-3[Epub ahead of print]
Armijo PR, Pagkratis S, Boilesen E, Tanner T, Oleynikov D (2018) Growth in robotic-assisted procedures is from conversion of laparoscopic procedures and not from open surgeons’ conversion: a study of trends and costs. Surg Endosc 32(4):2106–2113. https://doi.org/10.1007/s00464-017-5908-z(Epub 2017 Oct 24)
Falavolti C, Gidaro S, Ruiz E, Altobelli E, Stark M, Ravasio G, Lazzaretti SS, Buscarini M (2014) Experimental nephrectomies using a novel telesurgical system: (The Telelap ALF-X)—a pilot study. Surg Technol Int 25:37–41
Gidaro S, Altobelli E, Falavolti C, Bove AM, Ruiz EM, Stark M, Ravasio G, Lazzaretti SS, Maurizio B (2014) Vesicourethral anastomosis using a novel telesurgical system with haptic sensation, the Telelap Alf-X: a pilot study. Surg Technol Int 24:35–40 PMID:24706079
Conflict of interest
NE. Samalavicius, V. Janusonis, R. Siaulys,M. Jasenas, O. Deduchovas,, R. Venckus,, V. Ezerskiene, R. Paskeviciute, G. Klimaviciute, have no conflict of interest.
All procedures performed were in accordance with ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, revised in 2000.
Informed consent was obtained from all patients for being included in this study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Samalavicius, N.E., Janusonis, V., Siaulys, R. et al. Robotic surgery using Senhance® robotic platform: single center experience with first 100 cases. J Robotic Surg 14, 371–376 (2020). https://doi.org/10.1007/s11701-019-01000-6
- Robotic surgery
- Minimally invasive surgery
- Senhance robotic system